In this podcast, Philadelphia cornea and glaucoma surgeon Brian Shafer, MD, discusses the procedures and processes involved ...
Stargardt programs address ABCA4 payload constraints via dual-AAV platforms (VG801, AAVB-039) and explore first ...
TECLens treated the first patient in a first-in-human trial assessing safety and efficacy of qCXL-based refractive correction ...
The conversation explored DME subtypes, treatment selection, and the roles of VEGF, ANG2, and inflammatory cytokines—particularly in severe or poorly controlled patients who respond inadequately to ...
Host Deborah Ristvedt, DO, welcomes Trattler to discuss how early inspirations, mentorship, collaboration, and a philosophy ...
The EnVision Summit—billed as the “ultimate gathering place for ophthalmic and optometric professionals”—has come to a close ...
Phentolamine is framed as a differentiated, preservative-free sympatholytic approach that modulates pupil dynamics without ciliary muscle activation, targeting near-vision improvement while ...
The authors of a new study 1 emphasized the clear visual benefits that low-vision patients experience during low-vision ...
Real-world evidence links higher injection frequency to better VA outcomes and reduced CST fluctuations, reinforcing ...
Ophthalmology Times, hosted by Douglas D. Koch, MD, Professor and Allen, Mosbacher, and Law Chair in Ophthalmology at the ...
The results of a phase 1b study that evaluated a potential new treatment for macular edema associated with inflammation, ...
Ocular Therapeutix has released positive topline results from SOL-1, its phase 3 superiority trial of AXPAXLI for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results